Dr. Agarwal’s Health Care Limited has received a Show Cause Notice from the GST authorities regarding discrepancies in its 2023-24 financial returns. The notice demands an explanation for potential tax liabilities, including interest and penalties, totaling ₹20.50 crore. The company is currently reviewing the claims and expects no material impact on its ongoing operations or financial health.
Overview of the Notice
On May 18, 2026, Dr. Agarwal’s Health Care Limited was served a notice by the Office of the Assistant Commissioner, GST & Central Excise, Chennai. The communication alleges various discrepancies in the tax filings for the 2023-24 financial year. The specified areas of concern include output turnover differences, tax payments under the Reverse Charge Mechanism, and issues related to input tax credit claims and e-invoicing compliance.
Financial and Operational Outlook
The total amount under dispute, including applicable interest and penalties, stands at ₹20.50 crore. The company has been granted a period of 30 days to provide a formal response to the authorities. Despite the receipt of this notice, the management has stated that they do not anticipate any significant adverse impact on the company’s financial position, general operations, or other corporate activities. The organization is actively preparing its response to address the points raised by the department within the prescribed timeframe.
Source: BSE
